Buy IGF-1 LR3 — Vendor Comparison & Prices

Compare IGF-1 LR3 prices across verified research peptide vendors. See live pricing, COA testing results, discount codes, and shipping speeds. Updated regularly.

IGF-1 LR3 is a long-acting variant of insulin-like growth factor 1, engineered with an N-terminal extension that significantly extends its half-life versus native IGF-1. This data shows the dose amounts, vial sizes, and bacteriostatic water volumes researchers most commonly select when reconstituting IGF-1 LR3.

Where to Buy IGF-1 LR3 for Research

Finding a trustworthy IGF-1 LR3 supplier requires comparing more than just sticker price. Vendors differ in vial size, peptide concentration, COA frequency, lab selection, and shipping speed. WPA aggregates this data into a single, filterable comparison so researchers can quickly identify the best overall value for IGF-1 LR3 without visiting each vendor individually.

All IGF-1 LR3 vendors listed on WPA have been reviewed for COA availability. We prioritize suppliers who publish independently verified purity results from named third-party laboratories with recent test dates.

What This IGF-1 LR3 Comparison Page Includes

  • Live IGF-1 LR3 pricing — Current prices across all tracked vendors, normalized to price per milligram for a fair apples-to-apples comparison regardless of vial size.
  • COA verification data — Third-party purity test results for IGF-1 LR3, including the lab name, purity percentage, and test date so researchers can assess source quality.
  • Vendor discount codes — Exclusive WPA researcher discount codes that reduce the cost of IGF-1 LR3 from participating vendors.
  • Vial size and strength comparison — IGF-1 LR3 is sold in multiple concentrations and formats. WPA compares available strengths so lower vial prices do not conceal a higher true cost per milligram.
  • Stock availability — Real-time in-stock status for IGF-1 LR3 listings so researchers can plan sourcing without delays.
  • Shipping and handling context — Smaller vials may require more frequent purchases, each with shipping costs. WPA surfaces total research cost context beyond vial price alone.

IGF-1 LR3 Vendor Selection Methodology

WPA evaluates IGF-1 LR3 suppliers on four primary criteria: COA quality (purity ≥98%, named independent lab, recent test date), pricing transparency (per-milligram cost clearly disclosed), stock reliability (consistent availability tracked over time), and community trust (based on anonymized researcher click and purchase data collected through WPA tools).

Vendors that cannot provide verifiable third-party testing for IGF-1 LR3 are flagged accordingly. Researchers are encouraged to cross-reference COA data against the lab's published results before placing an order.

Frequently Asked Questions: IGF-1 LR3 Sourcing & Pricing

Why compare IGF-1 LR3 by price per milligram instead of vial price?

Vendors offer IGF-1 LR3 in different vial sizes and concentrations. A lower vial price may contain less total peptide, resulting in a higher cost per milligram. WPA normalizes all IGF-1 LR3 listings to $/mg so researchers see the true comparative value across all suppliers and strengths.

What should I check in a IGF-1 LR3 COA before purchasing?

A valid IGF-1 LR3 certificate of analysis should include the purity percentage (ideally 98% or higher), the name of an independent third-party laboratory, a recent test date (within the last 12 months), and the actual measured mass relative to the label claim. COAs without a named lab or with outdated test dates are red flags regardless of the purity figure listed.

How often does WPA update IGF-1 LR3 vendor data?

World Peptide Association monitors IGF-1 LR3 pricing and stock status continuously. COA verification status is updated whenever vendors publish new lab results. Researchers can check the "COA date" column on this page to see how recently each vendor's IGF-1 LR3 testing was performed.

Why do IGF-1 LR3 prices vary between vendors?

IGF-1 LR3 price variation reflects differences in vial size, synthesis source, testing frequency, and vendor business model. Suppliers investing in frequent independent COA testing and quality control typically have higher baseline costs. WPA's per-milligram normalization helps researchers identify whether a lower price represents genuine savings or simply a smaller vial.